Does Enoxaparin treatment have any effects on the placenta in women with unexplained histories of habitual abortion? A case control study


Özdemir A. Z., Ayas B., Kocaman A., Önal M., Dogenci G., Koçak İ.

SAO PAULO MEDICAL JOURNAL, cilt.138, sa.4, ss.275-281, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 138 Sayı: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1590/1516-3180.2019.0511.r1.16042020
  • Dergi Adı: SAO PAULO MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.275-281
  • Anahtar Kelimeler: Livebirth rate, Trophoblast proliferation, Vascularization, LOW-DOSE ASPIRIN, RECURRENT MISCARRIAGE, EXPRESSION, APOPTOSIS, BCL-2, DEPOSITION
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

BACKGROUND: It is very common to offer low molecular weight heparin (LMWH) medications to women with unexplained habitual abortion, to increase the livebirth rate. Although no benefit from LMWH has been clearly demonstrated, examination of the effects of enoxaparin on placental structure is lacking.